Viatris Recalls Xanax XR 3mg Tablets Nationwide Due to Dissolution Failure
核心洞察
Viatris Inc. has initiated a nationwide recall of Xanax XR 3mg extended-release tablets after the medication failed dissolution specifications during quality control testing.
The recall affects lot #8177156 with expiration date 02/28/2027, distributed to patients between August 27, 2024, and May 29, 2025.
The FDA classified this as a Class II recall, indicating potential temporary or medically reversible adverse health consequences.
Viatris Inc. has issued a nationwide recall of a specific lot of Xanax XR (alprazolam) extended-release tablets after the medication failed to meet dissolution specifications during quality control testing. The recall, initially initiated by the pharmaceutical company on March 17, was classified by the U.S. Food and Drug Administration as a Class II recall on April 8.
Recall Details and Affected Products
The recall specifically targets lot #8177156 of Xanax XR 3mg extended-release tablets packaged in 60-tablet bottles. These affected medications carry an expiration date of February 28, 2027. According to the California State Board of Pharmacy, the recalled tablets were distributed to patients between August 27, 2024, and May 29, 2025.
The FDA has not disclosed the total number of pills or bottles included in this recall.
Quality Control Failure
The recall was triggered because the medication "failed dissolution specifications," indicating that the drug did not meet quality control standards for how it dissolves or breaks down in the body. This dissolution failure could potentially affect the medication's therapeutic efficacy and patient safety.
Safety Classification and Health Implications
The FDA designated this recall as Class II, which means "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences," with the probability of serious adverse health consequences being remote. This classification indicates that while the risk is not immediately life-threatening, patients should take the recall seriously.
Patient Action Required
Patients who have been prescribed the affected Xanax XR tablets should stop taking them immediately and dispose of them safely. Healthcare providers and patients can identify the recalled medication by checking for lot number 8177156 and the expiration date of 02/28/2027 on the bottle label.
About Xanax and Its Medical Use
Xanax is a benzodiazepine medication that works by enhancing the activity of certain neurotransmitters (搜索) in the brain. The drug is commonly prescribed to treat anxiety disorders (搜索), anxiety caused by depression (搜索), and panic disorders (搜索) with or without agoraphobia. According to the Cleveland Clinic, "It works by helping your nervous system calm down." Xanax ranks among the most commonly prescribed benzodiazepines in the United States.